Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No ACG news, except a coop between Verenetics and ACG, and I have reason to believe ACG to use both techs combined in a while...not sure btw.
You guys seen the Trutag Colorcon joint development agreement?
Dont know what to think, for instance about whether adnas and trutag are combinable or mutually exclusive
link to the pr
Good written piece on cbd in UK
https://irp-cdn.multiscreensite.com/51b75a3b/files/uploaded/Report%20%7C%20CBD%20in%20the%20UK%20-%20Exec%20Summary.pdf" rel="nofollow" target="_blank" >link
ul-and-safetraces-transform-palm-oil-sustainability-practices
Hmmm... didnt adnas had a strategic partnership with UL too?
I still think its odd that Safetraces would be able to do the same as Adnas is able to, but only with a handfull of patents...just like in the turkish fertilizer chapter. Hence I still believe it to be possible, better yet: probable Adnas and Safetraces to be more than just competitors somehow. I think applying dnatags for food requires somehow a SignatureDNA light version, and I think Safetraces mainly is specialised in tagging equipment like the DART3000 system. I know Safetraces doesnt produce its own tags cos years ago I asked them, but they wouldnt tell where they were made.
Any thoughts?
Any thought is welcome
big-macao-tobacco-enters-booming-asia-hemp-market alongside with CannAcubed
Another crumb
nadler-harris-to-introduce-bill-decriminalizing-pot-expunge-prior-convictions
Seems US slowly coming to sense regarding pot
Nice short CAR-T history piece:how-scientists-built-living-drug-to-beat-cancer
Good HouseKeeping ranks Wamsutta Pimacott on top in cat. Luxery cotton sheets:
best-sheets-reviews
What does this mean?
a-amp-l-canada-laboratories-to-be-lead-analytical-testing-facility-in-shoppers-drug-mart-and-trutrace-pilot-traceability-program-for-medical-cannabis
I guess A&L laboratories is certified by adnas to conduct analyses (a bit like UL?)...other thoughts?
Seems yet again a positive steppingstone
home textile today with Wayne Buchen (and others)
Stahls Michael Costello webinar on dnatagging leather supply chain
Wondering if Evotecs new spinoff Breakpoint Therapeutics will test/use LinearX dna...
evotec-and-venture-capital-consortium-form-breakpoint-therapeutics-gmbh-5831?utm_campaign=Press...
I am wondering if Lonza's Capsugel might be an Adnas prospect (or wether the exclusive Colorcondeal makes this impossible) especially since last month Auxly's subsidiairy DoseCann signed a collaboration with Lonza for formulated Capsules
link to that
Congrats with those winning US women Mike...Netherlands needed to stunt big time in order to win the game, which they didn't. Liked the game though, and runnerup isnt a shame either.
Adnas from here on. Got me some time this month to dig in and connect dots once again...suggestions?
Hmmm...I recall Dasmortes fiercely stating no market would exist for linear dna to begin with...where we now see Evotec and apparently multiple other parties at least seem interested enough to benchmark the hell out of it.
Dasmortes on the other hand seems nonexistent these days...
I think Cheekie when folks without proper knowledge hear about synthesized dna (although from botanical source) they sometimes, apparently, think of it as artificial...
Not all coverage is as accurate as it should be. Just the other day a short piece mentioned Theracann being an Adnas division.
I cant help but feeling the pps should be 0.50 at the time ..... will happen. But what? And why? And for whom?
Any ideas?
Again: Connecting a dot further:
shivom-and-trutrace-technologies-to-explore-clinical-solutions-for-cannabis-market...
shivom
When one might, like me, foresee a future in which all pharmaceuticals, including cannabisbased products will eventually be based on individual (client/patient/customer) dna analysis, potentially leading to personalised eh... everything, so I view recent developments as mere underwriting that very future. Adnas imho will be the company guaranteeing everyone that "Your stuff" actually is your stuff (and hence the indisputable proven original, pure, nondilluted, green, sustainable, effective, etc).
BTW... one of Shivoms partners is Singularitynet.io
Which in its turn partially is involved in:
Opencog, an in my view very interesting movement
Connecting a dot further:
shivom-and-trutrace-technologies-to-explore-clinical-solutions-for-cannabis-market...
evotec-se-places-first-schuldschein-promissory-note-worth-eur-250-m
So imho based on pr and below, linearxhas been very close in this instance with Celgene...but I suspect more big pharma very close:
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. Drug discovery solutions are provided in form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of innovative drug candidates and consulting arrangements. The Company operates worldwide and has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in the areas of neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. By leveraging this expertise, Evotec intends to develop best-in-class and first-in-class differentiated therapeutics on its systematic, unbiased and comprehensive infrastructure.
Evotec has long-term discovery alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB, and others. In addition, the Company has existing development partnerships and product candidates both in clinical and pre-clinical development. These include partnerships with e.g. with Sanofi in the field of diabetes and cancer immunotherapy, with Pfizer in the field of tissue fibrosis, with Bayer in the field of kidney diseases and with Celgene in the field of neurodegenerative diseases.
Evotec is built on integrated drug discovery know-how of over 20 years and is a leading player in the drug discovery field. The Company’s headquarters are located in Hamburg, Germany. Additional operating sites exist in Abingdon and Manchester, UK, Goettingen and Munich, Germany, Verona, Italy, Branford, Princeton and Watertown, USA, Basel, CH as well as Lyon and Toulouse, France. Evotec has more than 2,500 employees worldwide.
Could someone straighten out the author of this little piece on Trutrace/theracann/adnas, regarding the last sentence (or have I been missing something?):
pot-startup-uses-blockchain-smoke
AND trutrace very recently got Canadas biggest pharmacychain as their partner....might be interesting for pharma future
canadas-largest-pharmacy-chain-partners-with-trutrace-technologies-inc
I am puzzled as to where ETCH biotrace stands as opposed to Strainsecure, as they both SEEM to use different tracers? Any ideas board?
On dna encoding for massive storage (and retrieval), a thing put aside as dreamworks by one of adnas' biggest criticaster at this board, I think its wonderful to see TwistBio meeting some competition:
Catalog in the news.
Not directly Adnas stuff although we did fantasize a bit bout it.
https://www.jpost.com/Israel-News/Medical-cannabis-to-be-made-available-by-prescription-for-certain-illnesses-589925" rel="nofollow" target="_blank" >some Israeli news
TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China
Date : 05/15/2019 @ 8:04AM
Source : Business Wire
Stock : Applied Dna Sciences (APDN)
Quote : 0.57 0.0 (0.00%) @ 4:00AM
TheraCann and CannAcubed Enter Collaboration Agreement to Validate Cannabis and Hemp Supply Chain in China
Print
Alert
Applied DNA Sciences, Inc. (NASDAQ:APDN)
Intraday Stock Chart
Today : Wednesday 15 May 2019
Click Here for more Applied DNA Sciences, Inc. Charts.
Alliance will Utilize Technology from Applied DNA Sciences in ETCH biotrace™ to Secure Supply Chains
Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today that partner TheraCann International Benchmark Corporation (“TheraCann”), a leading full service international cannabis consultancy and technology firm, in conjunction CannAcubed Pte Ltd (CannAcubed), a pioneer in the China cannabis space with a focus on building the world’s largest diversified cannabis operations, has formed an agreement focused on the implementation of TheraCann’s molecular-tagging ETCH biotrace™ technology for the industrial hemp and cannabinoid markets in China.
TheraCann’s ETCH biotrace™ platform uses both a physical molecular tag (exclusively supplied by Applied DNA Sciences) and a non-appendable distributed ledger (blockchain) to provide forensic levels of traceability of cannabis and cannabis derivatives at any point in the supply chain. Whether introduced at the farmer, processor, manufacturer, or at packaging, ETCH biotrace links a unique molecular tag to the cannabis plant that will survive extraction or conversion into new products within the supply chain.
“The base technology behind ETCH biotrace has enjoyed a long and proven track record in the cotton industry and other global supply chains,” said Dr. James Hayward, President and CEO of Applied DNA Sciences and partner to TheraCann on the technology; “The molecular tags used in the ETCH biotrace system are considered GRAS (Generally Recognized as Safe). The ETCH molecular tags are very small; too small to function as genes and are non-GMO. Tags are typically applied at a ratio of parts per billion, levels too low to have any impact on form or function, or the biological properties of cannabis or hemp. The opportunity to supply molecular tags to TheraCann on a large commercial scale to support the CannAcubed project leverages our core competency in large-scale taggant supply and authentication.”
The rapid global adoption of cannabis legislation has accelerated the need to secure and truly validate cannabis supply. Current systems, many of which rely on RFID or bar code technologies, are capable of accurately tracking cannabis supply chains through the cultivation stage but cannot forensically track cannabis and/or hemp derivative products back to a specific source once the physical tags and packaging are removed or the product is mixed with other suppliers.
“CannAcubed’s focus will be from tracking inception of an individual plant or crop, through harvest, processing, and distribution, all the way to the point of sale to the patient, said Glen Davis, Chief Executive Officer at CannAcubed. “This collaboration with TheraCann and ETCH biotrace provides visibility into the cannabis ‘chain of custody ‘, tracking cannabis supply chains with the ultimate aim to create a successful, sustainable and professional cannabis industry that is legitimately, safely and responsibly bringing cannabis to China, and the world.”
“TheraCann is excited to fully introduce this breakthrough technology to the Chinese market. Global regulatory bodies, large industrial hemp producers and cannabis brands have been somewhat limited by their reliance on traditional “seed-to-sale” systems,” said Jason Warnock, Chief Executive Officer of TheraCann International Benchmark Corporation. “The size and scale of these industrial markets require new and more complete solutions to facilitate global commerce in the sector.”
The CannAcubed project has been granted large-scale areas of land to cultivate, process, manufacture and export cannabis in all its forms. Once complete, it will position CannAcubed as one of the world’s largest supplier and validator of high-grade pure CBD Oil, and Pharmaceutical grade Isolate. Within China, CannAcubed will continue to work closely with Government & Private sector around the Textiles, Clean Energy, and Bio-New Materials sector.
Leading up to the collaboration with TheraCann, CannAcubed has been working with some of China’s largest organizations to build the world’s first ever environmental Industrial Hemp Eco-Park in the Yunnan province.
More information about ETCH biotrace is available at www.etchbio.solutions
http://cannabizdaily.co/blog/israeli-company-begins-clinical-trial-sublingual-cannabis-tablets/" rel="nofollow" target="_blank" >israeli-company-begins-clinical-trial-sublingual-cannabis-tablets...and I think: Colorcon ! Who's with me?
Panaxia just added a Nobelprize winner to the board
And Canopy bought C3 in Germany
https://www.forbes.com/sites/sarabrittanysomerset/2019/04/05/israel-decriminalizes-adult-use-cannabis-during-cannatech-conference-in-tel-aviv/#685fa9de5dff" rel="nofollow" target="_blank" >israel-decriminalizes-adult-use-cannabis-during-cannatech-conference-in-tel-aviv
I really dont have a clue, but to answer anyway: Modest income from co-developing gene therapy and vaccins researchers, which will come from more orders for custom dna, might be there rather quick (within a year I would think). Big bucks are expected when better human trial results due to nonviral methods, come in and possibly might lead to a paradigm shift.
I do believe petrsonalized gene thetapies are a big poart of pharma future. My question is if Adnas methods will serve PERSONALISATION in ways better than.others, and I.mea n not only for treatments but also for fashion, food, and "code" in general
Couple of weeks ago avectas-raises-10-million-in-equity-finance
Amd Avectas will be at ASGCT this week in Washington with a posterpresentation :
From the Avectas site
Good news indeed
Wondering if Theracann is or will be close to the Dutch cannabis market...as closed loop coffeeshop experiments gear up and Bedrocan potentially losing its country monopoly. I at least made sure some parties knowing of etch biotrace a while back...
netherlands-to-expand-cannabis-production-potentially-jeopardizing-bedrocans-monopoly